(Q43293458)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673085%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Isoprostenes as indicators of oxidative stress in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673085%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

Anna Dietrich-Muszalska

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673085%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Beata Olas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673085%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

2

Beata Olas

1 reference

18 November 2017

Anna Dietrich-Muszalska

series ordinal

1

1 reference

18 November 2017

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673085%20AND%20SRC:MED&resulttype=core&format=json

World Journal of Biological Psychiatry

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673085%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673085%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673085%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

27-33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673085%20AND%20SRC:MED&resulttype=core&format=json

The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Isoprostanes: novel bioactive products of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Vascular biology of the isoprostanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Determinants of F2-isoprostane biosynthesis and inhibition in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Oxidative stress in blood platelets from schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Schizophrenia as a membrane lipid disorder which is expressed throughout the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Schizophrenia as a prostaglandin deficiency disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Fatty acid levels in the brains of schizophrenics and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Oxidative stress during treatment with first- and second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Antioxidants: an integrative approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

The isoprostane 8-epi-PGF(2alpha) is a valuable indicator of oxidative injury in human heart valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Isoprostanes and related compounds: update 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Measurement of F(2)-isoprostanes unveils profound oxidative stress in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

The isoprostanes: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Total synthesis of isoprostanes: discovery and quantitation in biological systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Phospholipid and eicosanoid signaling disturbances in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Are isoprostanes a clinical marker for antioxidant drug investigation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

A nomenclature system for the isoprostanes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Polyunsaturated fatty acids, prostaglandins, and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Reduced status of plasma total antioxidant capacity in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263

Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701361263